Home › Funds › ESSEX INVESTMENT MANAGEMENT CO LLC › KNSA

ESSEX INVESTMENT MANAGEMENT CO LLC position in KNSA

KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A · Health Care

ESSEX INVESTMENT MANAGEMENT CO LLC reported holding 202,021 shares of KNSA (KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A) in its Q3 2026 13F filing — a position valued at US$15.1M, representing 2.24% of its reported portfolio and ranking #2 among its reported holdings. ESSEX INVESTMENT MANAGEMENT CO LLC has disclosed KNSA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)202.02K sh
Reported value held$15.07M
Portfolio Weight2.24%
First reportedQ3 2023
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How ESSEX INVESTMENT MANAGEMENT CO LLC's KNSA position evolved

ESSEX INVESTMENT MANAGEMENT CO LLC first disclosed a stake in KNSA in Q3 2023 at 185,853 shares (US$3.2M). The position peaked in Q2 2026 at 241,382 shares, worth US$15.4M. Across 13 filings, ESSEX INVESTMENT MANAGEMENT CO LLC increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 202,021 shares valued at US$15.1M — a reduction of -39,361 shares quarter over quarter.. Notable position changes include a 44% increase in Q3 2025 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 185.85K $3.23M New
Q4 2023 171.89K $3.01M Reduce
Q1 2024 172.74K $3.41M Hold
Q2 2024 199.80K $3.73M Add
Q3 2024 200.52K $5.01M Hold
Q4 2024 173.80K $3.44M Reduce
Q1 2025 172.67K $3.83M Reduce
Q2 2025 171.44K $4.74M Reduce
Q3 2025 247.30K $9.60M Add
Q4 2025 250.97K $10.35M Add
Q1 2026 249.28K $12.00M Reduce
Q2 2026 241.38K $15.44M Reduce
Q3 2026 202.02K $15.07M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KNSA and 13F data

KNSA (KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A) is a Health Care company. 48 other funds we track also report a position in KNSA — the largest reported positions include Rubric Capital Management LP (US$255.8M), BAKER BROS. ADVISORS LP (US$181.3M), TANG CAPITAL MANAGEMENT LLC (US$144.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KNSA

All KNSA fund holders →

FAQ

How long has ESSEX INVESTMENT MANAGEMENT CO LLC held KNSA?

ESSEX INVESTMENT MANAGEMENT CO LLC has disclosed KNSA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ESSEX INVESTMENT MANAGEMENT CO LLC's current position in KNSA?

As of Q3 2026, ESSEX INVESTMENT MANAGEMENT CO LLC holds 202.02K shares of KNSA (KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A), valued at $15.07M, representing 2.24% of its reported portfolio and ranking #2.

Has ESSEX INVESTMENT MANAGEMENT CO LLC been buying or selling KNSA?

In the latest 13F filing (Q3 2026), ESSEX INVESTMENT MANAGEMENT CO LLC reduced its position in KNSA. The position peaked in Q2 2026 at 241.38K shares.

Which other funds hold KNSA?

Other major institutional holders of KNSA include Rubric Capital Management LP, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.